6d
News Medical on MSNSt. Jude researchers improve brain disease diagnosis with PET imaging and ALS drugPositron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...
In a report released on March 7, Niraj Shah from Goldman Sachs maintained a Buy rating on ALS Ltd. (CPBLF – Research Report), with a price target of A$17.75. The company’s shares closed last ...
“She was also a proud educator.” While she was unable to sing in her later years due to having ALS, a progressive disease that affects the brain and spinal cord, Flack remained creative in ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully help contribute to ending ALS.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH ...
IRVINE, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., Chief Scientific Officer and President, will ...
NBC News on MSN16d
Roberta Flack, Grammy-winning singer of ‘Killing Me Softly with His Song,’ dies at 88Flack’s music was introduced to a new generation thanks to the Fugees and Lauryn Hill, whose cover of “Killing Me Softly with ...
Amanda Sifford is among the few with a genetically inherited form of ALS. With more than a dozen cases in her family, they participated in a study that led to the drug Qalsody. “That’s when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results